Qianxin Wu BS, BA, MSc, PhD

Qianxin obtained her MSc and PhD degrees in biomolecular medicine from Imperial College London. During her PhD studies, she worked on understanding the crosstalk between microRNA and metabolites using a metabolic surgery model system in Nigel Gooderham’s laboratory. In 2014, she joined Tudor Fulga lab at Oxford University to develop novel CRISPR based biotechnology (GenERA) to study RNA cis-regulatory elements. Qianxin joined Wellcome Trust Sanger Institute in 2017, she is currently working on developing CRISPR and single cell based technology to study functional regions in the non-coding genome.